VANCOUVER, British Columbia, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a neurology-focused biopharmaceutical company, today announced that the company will host an investor webinar with two leading key opinion leaders (KOLs) focused on major depressive disorder.
Webinar: | "XEN1101 and the Major Depressive Disorder (MDD) Landscape: A Discussion with KOLs" |
Date: | Tuesday, September 19, 2023 |
Time: | 11:30 am – 1 pm ET Eastern Time (8:30 am – 11 am Pacific Time) |
Link: | Participants can register and access the webinar on the Investors section of Xenon's website. |
Format: | Questions may be submitted (via chat function) ... |